Page 43 - American College of Allergy, Asthma and Immunology 2024 Annual Scientific Meeting Registration Program

Monday General Sessions
8:00 – 9:30 am
Plenary
The 2025 Severe or Difficult-
to-Control Asthma Practice
Parameter: A Sneak Preview
Moderators: Jay A. Lieberman, MD, FACAAI; and Michael S. Blaiss, MD, FACAAI
This symposium will give learners a look at the upcoming severe asthma practice parameter. It will delve into the latest science and possible recommendations regarding severe asthma. Attendees will learn about the burden of severe asthma and the comparative efficacy of various treatments.
Track: Asthma and Respiratory/Sleep Disorders
Welcome and Introductions
Jay A. Lieberman, MD, FACAAI; and Michael S. Blaiss, MD, FACAAI
The Health Problem and Burden of Severe or Difficult- to-Control Asthma
Giselle S. Mosnaim, MD, MS, FACAAI
The Comparative Efficacy and Safety Among Biologics, Macrolides and Thermoplasty for Severe or Difficult-to- Control Asthma
Leonard B. Bacharier, MD, FACAAI
The Comparative Efficacy and Safety of Reliever Therapies for Severe or Difficult-to-Control Asthma Bradley E. Chipps, MD, FACAAI
Bela Schick Lecture
Don’t Be Afraid To Pivot: Changing Your Career Rather Than Abandoning It
Melinda M. Rathkopf, MD, MBA, FACAAI
Questions & Discussion
9:45 – 11:00 am
Symposium
What Is New in Drug Allergy?
Moderators: Mariana C. Castells, MD, PhD, FACAAI; and Lily Li, MD
This session will review recent advances in drug hypersensitivity, with a particular focus on updates in diagnostic testing modalities and the impact of delabeling on patient clinical outcomes.
Track: Food & Drug Allergy and GI Disorders Welcome and Introductions
Mariana C. Castells, MD, PhD, FACAAI; and Lily Li, MD
Translating Updates in HLA/Genetic Testing Into Clinical Care of Patients With Drug Allergies
Elizabeth J. Phillips, MD
Evaluation of Delayed Drug Reactions Patch? Intradermal? Or Challenge?
David A. Khan, MD, FACAAI
Tools at Your Fingertips for Evaluation of Drug Allergy
Aleena Banerji, MD
Questions & Discussion
9:45 – 11:00 am
Symposium
Updates in Primary
Immunodeficiency
Moderators: Stanley M. Fineman, MD, MBA, FACAAI; and Juan Carlos Murillo Delgado, MD, FACAAI
The session will address the changing landscape of primary immunodeficiency, including newly identified conditions, along with optimal diagnostic and management strategies.
Track: Clinical Immunology and Autoimmune Diseases
Welcome and Introductions
Stanley M. Fineman, MD, MBA, FACAAI; and Juan Carlos Murillo Delgado, MD, FACAAI
Diagnostic Testing of Humoral and Cellular Immunodeficiency Beyond Conventional Methods Jordan S. Orange, MD, PhD, FACAAI
Management With Immunoglobulin Replacement
Charlotte Cunningham-Rundles, MD, PhD
Management of Noninfectious Complications in PIDD
John (Jack) M. Routes, MD, FACAAI
Questions & Discussion
Continues on next page
Register online at: annualmeeting.acaai.org 43 Table of Contents